Embecta Financial Statements From 2010 to 2026
| EMBC Stock | USD 11.66 0.22 1.85% |
Check Embecta Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Embecta Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Embecta financial statements analysis is a perfect complement when working with Embecta Corp Valuation or Volatility modules.
Check out the analysis of Embecta Corp Correlation against competitors. Embecta Corp Company Current Valuation Analysis
Embecta Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Embecta Corp Current Valuation | 1.91 B |
Most of Embecta Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Embecta Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Embecta Corp has a Current Valuation of 1.91 B. This is 86.71% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 88.52% higher than that of the company.
Embecta Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Embecta Corp's current stock value. Our valuation model uses many indicators to compare Embecta Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Embecta Corp competition to find correlations between indicators driving Embecta Corp's intrinsic value. More Info.Embecta Corp is rated # 2 in return on asset category among its peers. It is rated # 4 in profit margin category among its peers fabricating about 0.53 of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for Embecta Corp is roughly 1.88 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Embecta Corp's earnings, one of the primary drivers of an investment's value.About Embecta Corp Financial Statements
Embecta Corp stakeholders use historical fundamental indicators, such as Embecta Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Embecta Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Embecta Corp's assets and liabilities are reflected in the revenues and expenses on Embecta Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Embecta Corp. Please read more on our technical analysis and fundamental analysis pages.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out the analysis of Embecta Corp Correlation against competitors. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.